Augmentin

Valsts: Jaunzēlande

Valoda: angļu

Klimata pārmaiņas: Medsafe (Medicines Safety Authority)

Nopērc to tagad

Lietošanas instrukcija Lietošanas instrukcija (PIL)
19-04-2020
Produkta apraksts Produkta apraksts (SPC)
19-04-2020

Aktīvā sastāvdaļa:

Amoxicillin sodium 1060.2mg equivalent to Amoxicillin 1000 mg;  ; Potassium clavulanate 238.25mg equivalent to Clavulanic acid 200 mg;  ;  ;  

Pieejams no:

GlaxoSmithKline NZ Limited

SNN (starptautisko nepatentēto nosaukumu):

Amoxicillin sodium 1060.2 mg (= Amoxicillin 1000 mg)

Deva:

1.2 g

Zāļu forma:

Powder for injection

Kompozīcija:

Active: Amoxicillin sodium 1060.2mg equivalent to Amoxicillin 1000 mg   Potassium clavulanate 238.25mg equivalent to Clavulanic acid 200 mg      

Vienības iepakojumā:

Vial, glass, single dose, Type I or Type III, 5 x 1.2g, 6 g

Klase:

Prescription

Receptes veids:

Prescription

Ražojis:

Istituto Biochimico Italiano Giovanni Lorenzini SpA

Ārstēšanas norādes:

AUGMENTIN is indicated for the short term treatment of common bacterial infections such as: -Upper Respiratory Tract Infections (including ENT): e.g. tonsillitis, sinusitis, otitis media -Lower Respiratory Tract Infections: e.g. acute exacerbations of chronic bronchitis, lobar and broncho-pneumonia -Genito-urinary Tract Infections: e.g. cystitis, urethritis, pyelonephritis, female genital infections -Skin and Soft Tissue Infections -Bone and Joint Infections: e.g. osteomyelitis -Other Infections: e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, septicaemia, peritonitis, post-surgical infections AUGMENTIN is indicated for prophylaxis against infection which may be associated with major surgical procedures such as gastro-intestinal, pelvic, head and neck, cardiac, renal, joint replacement and biliary tract surgery.

Produktu pārskats:

Package - Contents - Shelf Life: Bottle, glass, Type III - 50 mL - 24 months from date of manufacture stored at or below 25°C - Vial, glass, single dose, Type I or Type III, 5 x 1.2g - 5 dose units - 24 months from date of manufacture stored at or below 25°C - Vial, glass, single dose, Type I or Type III, 10 x 1.2g - 10 dose units - 24 months from date of manufacture stored at or below 25°C

Autorizācija datums:

1986-08-21

Lietošanas instrukcija

                                1
AUGMENTIN INJECTION
POTASSIUM CLAVULANATE/AMOXICILLIN SODIUM EQUIVALENT TO 100 MG
CLAVULANIC ACID/500 MG
AMOXICILLIN
POTASSIUM CLAVULANATE/AMOXICILLIN SODIUM EQUIVALENT TO 200 MG
CLAVULANIC ACID/1 G
AMOXICILLIN
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some
common questions about
AUGMENTIN. It does not
contain all the available
information. It does not take
the place of talking to your
doctor or pharmacist.
Please read this leaflet before
you start using AUGMENTIN.
If you are helping someone
else take AUGMENTIN,
please read this leaflet before
you give the first dose.
All medicines have risks and
benefits. Your doctor has
weighed the expected
benefits against possible risks
of you using AUGMENTIN. If
you have any concerns about
using this medicine, ask your
doctor or pharmacist.
Keep this leaflet with the
medicine. You may need to
read it again.
WHAT AUGMENTIN IS
USED FOR
AUGMENTIN is an antibiotic
used to treat infections in
different parts of the body
caused by bacteria.
AUGMENTIN will not work
against infections caused by
viruses such as colds or the
flu.
AUGMENTIN is also used to
prevent infection from major
surgery.
AUGMENTIN is an antibiotic
that belongs to a group of
medicines called penicillins.
These antibiotics work by
killing the bacteria that are
causing your infection.
This medicine is available
only with a doctor’s
prescription.
BEFORE YOU TAKE
AUGMENTIN
_DO NOT TAKE AUGMENTIN _
_IF: _

you have an allergy to
AUGMENTIN, other
penicillins or any of the
ingredients listed at the
end of this leaflet.
Some of the symptoms of
an allergic reaction may
include skin rash, itching,
difficulty breathing.

you have had an allergic
reaction to
cephalosporins (another
type of antibiotic).
You may have an
increased chance of
being allergic to
AUGMENTIN if you are
allergic to cephalosporins.

you have had liver
disease or yellowing of
the skin and/or eyes, also
called jaundice when you
have taken
amoxicillin/clavulanic acid
(or AUGMENTIN) before.

the packaging is t
                                
                                Izlasiet visu dokumentu
                                
                            

Produkta apraksts

                                1
NEW ZEALAND DATA SHEET
1.
PRODUCT NAME
AUGMENTIN 600 mg and 1.2 g powder for injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
AUGMENTIN 600 mg: Each vial contains amoxicillin sodium equivalent to
500 mg of
amoxicillin and potassium clavulanate equivalent to 100 mg of
clavulanic acid.
AUGMENTIN 1.2 g: Each vial contains amoxicillin sodium equivalent to 1
g of
amoxicillin and potassium clavulanate equivalent to 200 mg of
clavulanic acid.
For the full list of excipients, see section 6.1 List of excipients.
3.
PHARMACEUTICAL FORM
Powder for injection. For reconstitution as an intravenous (IV)
injection or infusion.
Vials containing a sterile white to off-white powder.
4.
CLINICAL PARTICULARS
4.1_ _
THERAPEUTIC INDICATIONS
AUGMENTIN should be used in accordance with local official
antibiotic-prescribing
guidelines and local susceptibility data.
AUGMENTIN is indicated for the short term treatment of common
bacterial infections
in adults and children such as:
UPPER RESPIRATORY TRACT INFECTIONS (INCLUDING ENT): e.g. tonsillitis,
sinusitis, otitis
media
LOWER RESPIRATORY TRACT INFECTIONS: e.g. acute exacerbations of
chronic bronchitis,
lobar and broncho-pneumonia
GENITO-URINARY TRACT INFECTIONS: e.g. cystitis, urethritis,
pyelonephritis, female
genital infections
SKIN AND SOFT TISSUE INFECTIONS
BONE AND JOINT INFECTIONS: e.g. osteomyelitis
OTHER INFECTIONS: e.g. septic abortion, puerperal sepsis,
intra-abdominal sepsis,
septicaemia, peritonitis, post-surgical infections
AUGMENTIN is indicated for prophylaxis against infection which may be
associated
with major surgical procedures such as gastro-intestinal, pelvic, head
and neck,
cardiac, renal, joint replacement and biliary tract surgery.
2
Susceptibility to AUGMENTIN will vary with geography and time. Local
susceptibility
data should be consulted where available, and microbiological sampling
and
susceptibility testing performed where necessary.
Infections caused by amoxicillin susceptible organisms are amenable to
AUGMENTIN treatment due to its amoxicillin content
                                
                                Izlasiet visu dokumentu
                                
                            

Skatīt dokumentu vēsturi